Novartis was one of the 39 companies that took the South African
government to court five years ago, in an effort to overturn the
country's medicines act that was designed to bring drug prices down.
Now Novartis is up to it again and is targeting India.
India produces affordable medicines that are vital to many people
living in developing countries. Over half the medicines currently used
for AIDS treatment in developing countries come from India and such
medicines are used to treat over 80% of the 80,000 AIDS patients in
Médecins Sans Frontières projects.
If Novartis is successful in its challenge against the Indian
government and its patent law, more medicines are likely to be patented
in India, making it very difficult for generic producers to make
affordable versions of them. This could affect millions of people
around the world who depend on medicines produced in India.
Tell Novartis it has no business standing in the way of people's right
to access the medicines they need. Sign on and urge Novartis to DROP
THE CASE against the Indian government.
http://www.msf.org/petition_india/can_eng.html
